Differences in c-fos gene product expression in cancers of the gall- bladder and biliary tract

Pathology International

Volumn 46, Issue 10, 1996, Pages 771-776

  Lee, C Soon ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

biliary tract cancers; c fos; gall bladder; immunohistochemistry; neoplasm; oncogene

Indexed keywords

CELL PROTEIN; GENE PRODUCT; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN C FOS;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT TUMOR; CHRONIC CHOLECYSTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; GALLBLADDER CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ONCOGENE C FOS; PRIORITY JOURNAL; ROKITANSKY SYNDROME; VATER PAPILLA CARCINOMA;

EID: 0029845894     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03547.x     Document Type: Article

References (40)

1. Albores-Saavedra J, Henson DE. Tumors of the gall-bladder and extrahepatic bile ducts. In: Atlas of Tumor Pathology, 2nd series, Fascicle 22. Armed Forces Institute of Pathology, Washington, 1984, 1-2.
2. Bennett RC, Jepson RP. Carcinoma of the gall-bladder. Aust. N.Z. J. Surg. 1965; 34: 278-283.
3. Diehl AK. Epidemiology of gall-bladder cancer: A synthesis of recent data. J. Natl Cancer Inst. 1980; 65: 1209-1214.
4. Piehler J, Crichlow RW. Primary carcinoma of the gall-bladder. Surg. Gynecol. Obstet. 1978; 147: 929-942.
5. Akwari OE, Van Heerden JA, Foulk WT, Baggenstoss AH. Cancer of the bile ducts associated with ulcerative colitis. Ann. Surg. 1975; 181: 303-309.
6. Alexander F, Rossi RL, O'Bryan M, Khettry U, Braasch JW, Walkins E Jr. Biliary carcinoma: A review of 109 cases. Am. J. Surg. 1984; 147: 503-509.
7. MacCarty RL, La Russo NF, May GR et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: Cholangiographic appearances. Radiology 1985; 156: 43-46.
8. Sameshima Y, Uchimura M, Muto Y, Maeda J, Tsuchiyama H. Coexistent carcinoma in congenital dilatation of the bile duct and anomalous arrangement of the pancreatico-bile duct: Carcinogenesis of coexistent gall-bladder carcinoma. Cancer 1987; 60: 1883-1890.
9. Strom BL, Hibberd PL, Soper KA, Stolley PD, Nelson WL. International variations in epidemiology of cancers of the extrahepatic biliary tract. Cancer Res. 1985; 45: 5165-5168.
10. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: Analysis of 96 cases. Ann. Surg. 1981; 194: 447-457.
11. Wise L, Pizzimbono C, Dehner LP. Periampullary cancer: A clinicopathologic study of sixty-two patients. Am. J. Surg. 1976; 131: 141-148.
12. Weinberg RA. Oncogenes, anti-oncogenes and the molecular bases of multistep carcinogenesis. Cancer Res. 1989; 49: 3713-3721.
13. Wynford-Thomas D. Oncogenes and anti-oncogenes: The molecular basis of tumour behaviour. J. Pathol. 1991; 165: 187-201.
14. Curran T, Miller AD, Zokas LM, Verma IM. Viral and cellular fos proteins: A comparative analysis. Cell 1984; 36: 259-268.
15. Kim K, Akoto-Amanfu E, Cherrick HM, Park NH. Anchorage-independent growth and the expression of cellular proto-oncogenes in normal human epidermal keratinocytes and in human squamous cell carcinoma cell lines. Oral Surg. Oral Med. Oral Pathol. 1991; 71: 303-311.
16. Mazurenko NN, Kogan EA, Sukhova NM, Zborovskaia IB. Synthesis and distribution of oncoproteins in tumour tissue. Vopr. Med. Khim. 1991; 37: 53-59.
17. Saint-Ruf C, Gerbault-Seureau M, Viegas-Pequignot E, Zafrani B, Cassingena R, Dutrillaux B. Proto-oncogene amplification and homogeneously staining regions in human breast carcinoma. Genes Chrom. Cancer 1990; 2: 18-26.
18. Tsuda T, Fukumoto Y, Hamamori Y, Yamashita T, Takai Y. Involvement of two intracellular messenger systems, protein kinase C and cyclic AMP, in the regulation of c-fos gene expression in human promyelocytic leukemia (HL-60) cells. J. Biochem. 1987; 102: 1579-1583.
19. Lee CS, Charalambous D. Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers. Zentralbl. Pathol. 1994; 140: 271-275.
20. Zerial M, Toschi L, Ryseck RP, Schuermann M, Müller R, Bravo R. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 1989; 3: 805-813.
21. Van Beveren C, van Straaten F, Curran T, Müller R, Verma IM. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 1983; 32: 1241-1255.
22. Miller AD, Curran T, Verma IM. c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene. Cell 1984; 36: 51-60.
23. Miller JR, Thomsen PD, Dixon SC, Tucker EM, Konfortov BA, Harbitz I. Synteny mapping of the bovine IGHG2, CRC and IGF1 genes. Anim. Genet. 1992; 23: 51-58.
24. Marx JL. The fos gene as 'master switch'. Science 1987; 237: 854-856.
25. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984; 311: 433-438.
26. Muller R, Wagner EF. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature 1984; 311: 438-442.
27. Draoui M, Chung P, Park M, Birrer M, Jakowlew S, Moody TW. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides 1995; 16: 289-292.
28. Herman WH, Simonson MS. Nuclear signalling by endothelin-1: A Ras pathway for activation of the c-fos serum response element. J. Biol. Chem. 1995; 270: 11 654-11 661.
29. Machwate M, Jullienne A, Moukhtar M, Lomri A, Marie PJ. c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells. Mol. Endocrinol. 1995; 9: 187-198.
30. Ito E, Nomura N, Narayanan R. Transcriptional regulation of early growth response genes in Fos-expressing PC-12 cells. Cell Regul. 1990; 1: 347-357.
31. Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl Acad. Sci. USA 1992; 89: 4042-4046.
32. Alexander RJ, Buxbaum JN, Raicht RF. Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosourea. Am. J. Med. Sci. 1992; 303: 16-24.
33. Cattabeni M, D'Incalci M, Broggini M. Differential expression of c-fos proto-oncogene in two subclones derived from a human ovarian cancer cell line. Cell Mol. Biol. 1995; 41: 255-263.
34. Urabe A, Nakayama J, Taniguchi S, Inoue M, Hori Y. Expression of the fos oncogene in B16 melanoma cells exhibiting different metastatic abilities. J. Dermatol. Sci. 1990; 1: 455-458.
35. Kroumpouzos G, Eberle J, Garbe C, Orfanos CE. p53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines. Pigment Cell Res. 1994; 7: 348-353.
36. Pai SR, Bird RC. Overexpression of c-fos induces expression of the retinoblastoma tumor suppressor gene Rb in transfected cells. Anticancer Res. 1994; 14: 2501-2508.
37. Urabe A, Nakayama J, Taniguchi S, Kuroki R, Hori Y. Expression of the fos oncogene in basal cell carcinoma. J. Dermatol. Sci. 1994; 8: 50-53.
38. Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br. J. Cancer 1992; 66: 106-112.
39. Wakita K, Ohyanagi H, Yamamoto Y, Tokuhisa, Saitoh Y. Over-expression of c-Ki-ras and c-fos in human pancreatic carcinomas. Int. J. Pancreatol. 1992; 11: 43-47.
40. Tratner I, Verma IM. Identification of a nuclear targeting sequence in the Fos protein. Oncogene 1991; 6: 2049-2053.